Two independent directors resign; new director appointed and committees reconstituted
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On 10 August 2026, the board appointed Nirav Madhusudan Soni as an additional non-executive, non-independent director. It accepted the immediate resignations of independent directors Jitendra Pradipbhai Parmar and Manish Shrichand Bachani, both citing personal reasons and insufficient time for company affairs. Each confirmed no other material reason. The board reconstituted its audit, nomination and remuneration, and stakeholder relationship committees.
The two exits may weigh on sentiment and raise continuity concerns, partly offset by a new appointment and committee changes.